Evolent HealthEVH +4.79%60 Gross Margin % is 16.88% as of Mar. 2026, which is 32% below its 10-year median of 25.00. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Evolent Health ranks worse than 83.84% on this metric.
Evolent Health Inc gross margin has been in long-term decline. The average rate of decline per year is -7.4%.
The historical rank and industry rank for Evolent Health's Gross Margin % or its related term are showing as below:
EVH'
s Gross Margin % Range Over the Past 10 Years
Min: 14.38 Med: 25 Max: 47.72
Current: 20.18
During the past 13 years, the highestGross Margin % of Evolent Health was 47.72%. The lowest was 14.38%. And the median was 25.00%.
EVH's Gross Margin % is ranked worse than 83.84% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs EVH: 20.18
Evolent Health had a gross margin of 16.88% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Evolent Health was -7.40% per year.
Evolent Health (NYSE:EVH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Evolent Health had a gross margin of 16.88% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Evolent Health Gross Margin % Related Terms
Evolent Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Evolent Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Evolent Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Evolent Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Evolent Health (EVH) has a Gross Margin % of 16.88% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Evolent Health and its competitors. This is 32% below median its historical median of 25.00. Over the past decade, Evolent Health's Gross Margin % has ranged from 14.38 to 47.72. According to the industry distribution chart, Evolent Health ranks #529 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 83.8%.
Is Evolent Health's Gross Margin % too high?
Evolent Health's current Gross Margin % of 16.88% is 32% below median its 10-year median of 25.00. Over the past 10 years, this metric has ranged from a low of 14.38 to a high of 47.72. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Evolent Health's value of 16.88% is 57.9% below this industry median. Based on the distribution chart, Evolent Health ranks #529 out of 631 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Gross Margin % compare to NRC and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #529 out of 631 companies for Gross Margin %. This places Evolent Health in the lower half of its industry. The industry median Gross Margin % is 40.09. Evolent Health's value of 16.88% is 57.9% below this benchmark. Historically, Evolent Health's own Gross Margin % has ranged from 14.38 to 47.72 over the past decade. While the company's 10-year median is 25.00 vs. the industry median of 40.09, Evolent Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evolent Health's current Gross Margin % of 16.88% is 57.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Gross Margin % is 16.88%, which is 32% below median its own 10-year median of 25.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.05, compared to a current price of $5.03 — trading 54.5% below its estimated fair value. The current Gross Margin % is 16.88%, which is 32% below median its 10-year median of 25.00 and 57.9% below the Healthcare Providers & Services industry median of 40.09. Evolent Health's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Evolent Health (EVH), the current Gross Margin % is 16.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.03 is trading 54.5% below its estimated GF Value™ of $11.05.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
Gross Margin %: 16.88% (32% below median its 10-year median of 25.00)
GF Value™: $11.05 vs. price of $5.03 (54.5% below fair value)
Industry Position: 57.9% below the Healthcare Providers & Services median (#529 of 631)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score
Get the complete analysis for EVH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
